FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoshitaka Fujii

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Phenomena

Polymorphism, Single-Stranded Conformational

Genes & Molecular Sequences

Genes, p53

Procedures

Anatomy

Tumor Cells, Cultured

Co-author Network

Publications

TOP 3
Kotaro Mizuno; Hirotaka Osada; HIROYUKI KONISHI; Yoshio Tatematsu; Yasushi Yatabe; Tetsuya Mitsudomi; Yoshitaka Fujii; Takashi Takahashi
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers.
N Haruki; Tomoko Harano; Akira Masuda; T Kiyono; Takashi Takahashi; Yoshio Tatematsu; S Shimizu; Tetsuya Mitsudomi; HIROYUKI KONISHI; Hirotaka Osada; Yoshitaka Fujii; T Takahashi
Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation.
N Haruki; Hiroko Saito; Tomoko Harano; S Nomoto; Takashi Takahashi; Hirotaka Osada; Yoshitaka Fujii; T Takahashi
Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in human lung cancers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoshitaka Fujii (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: Kotaro Mizuno; Hirotaka Osada; HIROYUKI KONISHI; Yoshio Tatematsu; Yasushi Yatabe; Tetsuya Mitsudomi; Yoshitaka Fujii; Takashi Takahashi
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers.
Oncogene 2002;21(15):2328-33.
2001: N Haruki; Tomoko Harano; Akira Masuda; T Kiyono; Takashi Takahashi; Yoshio Tatematsu; S Shimizu; Tetsuya Mitsudomi; HIROYUKI KONISHI; Hirotaka Osada; Yoshitaka Fujii; T Takahashi
Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation.
The American journal of pathology 2001;159(4):1345-52.
2001: N Haruki; Hiroko Saito; Tomoko Harano; S Nomoto; Takashi Takahashi; Hirotaka Osada; Yoshitaka Fujii; T Takahashi
Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in human lung cancers.
Cancer letters 2001;162(2):201-5.
2000: N Haruki; Hiroko Saito; Yoshio Tatematsu; HIROYUKI KONISHI; Tomoko Harano; Akira Masuda; Hirotaka Osada; Yoshitaka Fujii; Takashi Takahashi
Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer.
Cancer research 2000;60(17):4689-92.
2000: N Haruki; Yasushi Yatabe; William D Travis; S Nomoto; Hirotaka Osada; S Nakamura; A Nakao; Yoshitaka Fujii; Takashi Takahashi
Characterization of high-grade neuroendocrine tumors of the lung in relation to menin mutations.
Japanese journal of cancer research : Gann 2000;91(3):317-23.
1999: S Nomoto; N Haruki; Takashi Takahashi; Akira Masuda; T Koshikawa; T Takahashi; Yoshitaka Fujii; Hirotaka Osada; T Takahashi
Search for in vivo somatic mutations in the mitotic checkpoint gene, hMAD1, in human lung cancers.
Oncogene 1999;18(50):7180-3.
1998: HIROYUKI KONISHI; Takashi Takahashi; K Kozaki; Yasushi Yatabe; Tetsuya Mitsudomi; Yoshitaka Fujii; T Sugiura; H Matsuda; T Takahashi; T Takahashi
Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers.
Oncogene 1998;17(16):2095-100.